StockNews.com Initiates Coverage on vTv Therapeutics (NASDAQ:VTVT)
Equities research analysts at StockNews.com initiated coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Free Report) in a research note issued on Thursday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, Alliance Global Partners assumed coverage on shares of vTv Therapeutics in a research note on Monday, December 9th. They […]
Equities research analysts at StockNews.com initiated coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Free Report) in a research note issued on Thursday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, Alliance Global Partners assumed coverage on shares of vTv Therapeutics in a research note on Monday, December 9th. They […]
